Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LOXITANE C

LOXAPINE HYDROCHLORIDE

Standard Dose
EQ 25MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LOXITANE C is listed in Drugs@FDA under application 017658 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LOXAPINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - EQ 25MG BASE/ML Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2025-01-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOXITANE C is listed in Drugs@FDA under application 017658 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LOXAPINE HYDROCHLORIDE Form and strength CONCENTRATE;ORAL - EQ 25MG BASE/ML Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2025-01-22 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.